Learning Objectives:

1.  Review the new anti-CD20 monoclonal antibodies.

2.  Review BTK inhibitors that are currently in trials.

3.  Briefly review the use of autologous hematopoietic stem cell transplant.

Session date: 
08/08/2023 - 8:00am to 9:00am CDT
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Carolyn Goldschmidt, DO